Cybin renames key subsidiaries under Helus reorganization plan
Reuters2026/08/14 11:44- Cybin outlined a corporate reorganization that will rebrand key subsidiaries under the Helus name in early January 2026.
- Cybin US Holdings will change its legal name to Helus US on Jan. 2, 2026.
- Cybin Corp. will be renamed Helus Pharma Corp. on Jan. 5, 2026.
- Cybin International Limited will become Helus International Limited on Jan. 6, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260

10-Yr Benchmark Govt Yields - Germany vs Other Nations